Folinic Acid Over: Rescue of Intermediate Dose Methotrexate

The article published by Haran et  al.1 is an important addition to the efforts being made to improve the use of methotrexate (MTX) in malignant disorders.

Source: Clinical Lymphoma, Myeloma and Leukemia - December 4, 2023 Category: Hematology Authors: Ian J. Cohen Tags: Letter to the Editor Source Type: research